Ratzinger Franz, Schuardt Michael, Eichbichler Katherina, Tsirkinidou Irene, Bauer Marlene, Haslacher Helmuth, Mitteregger Dieter, Binder Michael, Burgmann Heinz
Department of Laboratory Medicine, Division of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria.
Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
PLoS One. 2013 Dec 11;8(12):e82946. doi: 10.1371/journal.pone.0082946. eCollection 2013.
Physicians are regularly faced with severely ill patients at risk of developing infections. In literature, standard care wards are often neglected, although their patients frequently suffer from a systemic inflammatory response syndrome (SIRS) of unknown origin. Fast identification of patients with infections is vital, as they immediately require appropriate therapy. Further, tools with a high negative predictive value (NPV) to exclude infection or bacteremia are important to increase the cost effectiveness of microbiological examinations and to avoid inappropriate antibiotic treatment. In this prospective cohort study, 2,384 patients with suspected infections were screened for suffering from two or more SIRS criteria on standard care wards. The infection probability score (IPS) and sepsis biomarkers with discriminatory power were assessed regarding their capacity to identify infection or bacteremia. In this cohort finally consisting of 298 SIRS-patients, the infection prevalence was 72%. Bacteremia was found in 25% of cases. For the prediction of infection, the IPS yielded 0.51 ROC-AUC (30.1% sensitivity, 64.6% specificity). Among sepsis biomarkers, lipopolysaccharide binding protein (LBP) was the best parameter with 0.63 ROC-AUC (57.5% sensitivity, 67.1% specificity). For the prediction of bacteremia, the IPS performed slightly better with a ROC-AUC of 0.58 (21.3% sensitivity, 65% specificity). Procalcitonin was the best discriminator with 0.78 ROC-AUC, 86.3% sensitivity, 59.6% specificity and 92.9% NPV. Furthermore, bilirubin and LBP (ROC-AUC: 0.65, 0.62) might also be considered as useful parameters. In summary, the IPS and widely used infection parameters, including CRP or WBC, yielded a poor diagnostic performance for the detection of infection or bacteremia. Additional sepsis biomarkers do not aid in discriminating inflammation from infection. For the prediction of bacteremia procalcitonin, and bilirubin were the most promising parameters, which might be used as a rule for when to take blood cultures or using nucleic acid amplification tests for microbiological diagnostics.
医生经常会面对有感染风险的重症患者。在文献中,标准护理病房常常被忽视,尽管这些病房的患者经常患有不明原因的全身炎症反应综合征(SIRS)。快速识别感染患者至关重要,因为他们需要立即接受适当的治疗。此外,具有高阴性预测值(NPV)以排除感染或菌血症的工具对于提高微生物检查的成本效益和避免不适当的抗生素治疗很重要。在这项前瞻性队列研究中,对标准护理病房中2384名疑似感染患者进行筛查,看是否符合两项或更多SIRS标准。评估了感染概率评分(IPS)和具有鉴别力的脓毒症生物标志物识别感染或菌血症的能力。在这个最终由298名SIRS患者组成的队列中,感染患病率为72%。25%的病例发现有菌血症。对于感染的预测,IPS的ROC-AUC为0.51(灵敏度30.1%,特异性64.6%)。在脓毒症生物标志物中,脂多糖结合蛋白(LBP)是最佳参数,ROC-AUC为0.63(灵敏度57.5%,特异性67.1%)。对于菌血症的预测,IPS表现稍好,ROC-AUC为0.58(灵敏度21.3%,特异性65%)。降钙素原是最佳鉴别指标,ROC-AUC为0.78,灵敏度86.3%,特异性59.6%,NPV为92.9%。此外,胆红素和LBP(ROC-AUC:0.65,0.62)也可能被视为有用的参数。总之,IPS以及广泛使用的感染参数,包括CRP或WBC,在检测感染或菌血症方面诊断性能较差。额外使用脓毒症生物标志物无助于区分炎症和感染。对于菌血症的预测,降钙素原和胆红素是最有前景的参数,可作为何时进行血培养或使用核酸扩增试验进行微生物诊断的依据。